{"id":"W2990253155","doi":"10.1634/theoncologist.2019-0501","title":"Lenvatinib Versus Sorafenib as First-Line Treatment of Unresectable Hepatocellular Carcinoma: A Cost–Utility Analysis","year":2019,"lang":"en","type":"article","venue":"The Oncologist","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre; University of Waterloo","funders":"Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Ontario Ministry of Research, Innovation and Science","keywords":"Lenvatinib; Sorafenib; Medicine; Hepatocellular carcinoma; Oncology; Internal medicine; Clinical trial","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006481194,0.001562047,0.002211738,0.002256135,0.0003690475,0.001615109,0.00135814,0.001553858,0.006103177],"category_scores_gemma":[0.01719058,0.0008501066,0.003791322,0.001630519,0.0005761363,0.001577952,0.000959538,0.001796298,0.0001863375],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005884109,"about_ca_system_score_gemma":0.003040511,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0144463,"about_ca_topic_score_gemma":0.006803239,"domain_scores_codex":[0.9973109,0.002064219,0.00007005497,0.000149852,0.0001885757,0.0002164411],"domain_scores_gemma":[0.9862857,0.01231542,0.000593601,0.0001446753,0.0003492611,0.0003112099],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.003221087,0.0003908739,0.004086745,0.000410506,0.001181102,0.0002089787,0.00003268804,0.9773883,0.0002432657,0.004440174,0.0007355256,0.007660754],"study_design_scores_gemma":[0.0008607789,0.001413333,0.003351947,0.0001179582,0.001555385,0.000119003,0.00008745781,0.9872858,0.0002133568,0.004422136,0.0005311978,0.00004169008],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.945752,0.006255805,0.02949016,0.002490811,0.0001164611,0.001352404,0.0031005,0.000109723,0.01133224],"genre_scores_gemma":[0.9940152,0.000847359,0.003375705,0.000158803,0.00002413782,0.0002303659,0.0005306631,0.00001107329,0.000806772],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0144463,"threshold_uncertainty_score":0.04269242,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1282177910948125,"score_gpt":0.3195378907818478,"score_spread":0.1913200996870353,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}